Endocrinology & Diabetes Care
Endocrinology practices and diabetes management centers treating hormonal, metabolic, and thyroid disorders.
- 5
- Verticals
Overview
Endocrinology & Diabetes Care covers endocrinology practices and diabetes-management centers treating hormonal, metabolic, and thyroid disorders. Demand is driven by the diabetes epidemic, the obesity crisis, and — increasingly — the GLP-1 weight-loss-drug boom that has pulled metabolic care into the spotlight.
It is a cognitive, chronic-care specialty with a structural shortage of endocrinologists, and demand far exceeds supply. Diabetes-management technology and value-based metabolic-care models are reshaping how care is delivered, with emerging consolidation interest.
Market snapshot
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so endocrinology is not separately sized.
Business model & economics
Revenue model
Office and chronic-care management reimbursement
Key economics
- Recurring revenue
- High
- EBITDA margin
- 12–22%
- Capex intensity
- Low
chronic diabetes and metabolic care
Characteristics
- Diabetes, obesity, and GLP-1 demand surging.
- Structural shortage of endocrinologists.
- Diabetes tech and value-based metabolic care emerging.
M&A deal context
Who’s acquiring
- Value-based metabolic-care platforms
- Emerging endocrinology MSOs
- Diabetes-care strategics
What’s driving deals
- Diabetes and GLP-1-driven demand.
- Endocrinologist shortage and access gaps.
- Value-based metabolic-care models.
Verticals in this segment
Find Endocrinology & Diabetes Care acquisition targets
Search Acquisera’s index for companies classified under Endocrinology & Diabetes Care (4.10.8) and build a targeted deal pipeline.
Search companies